Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.

TitleGynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.
Publication TypeJournal Article
Year of Publication2014
AuthorsFujiwara, H, Yokota, H, Monk, BJ, Treilleux, I, Devouassoux-Shisheboran, M, Davis, A, Kim, J-W, Mahner, S, Stany, M, Pignata, S, Ray-Coquard, I, Fujiwara, K
JournalInt J Gynecol Cancer
Issue9 Suppl 3
Date Published11/2014
KeywordsAdenocarcinoma, Combined Modality Therapy, Consensus, Female, Humans, Medical Oncology, Practice Guidelines as Topic, Societies, Medical, Uterine Cervical Neoplasms

Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.

Alternate JournalInt. J. Gynecol. Cancer
PubMed ID25341589